Fremanezumab for the Treatment of Migraine and Major Depressive Disorder - podcast episode cover

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

JAMA Neurology Author Interviews
May 05, 2025•21 min
--:--
--:--
Listen in podcast apps:
Metacast
Apple Podcasts
Spotify
Download
YouTube
Overcast
Pocket Casts
Episodes.fm
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast